Conference to Clinic Highlights From the 2025 ASH Annual Meeting: Key Studies in Leukemias

Content Format:

Conference Coverage

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

1.00
A New Revolution in AML Treatment: Can Menin Inhibitors Follow the Path of FLT3 and IDH Inhibitors?

Content Format:

Slideset

Credit Type:

--

Credits:

--
Amplifying the Academic/Community Connection for Optimizing Asparaginase Therapy in ALL

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
PulseCast: Highlights in Leukemias From the 2025 ASH Annual Meeting

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--
Amplifying the Academic/Community Connection to Equip HCPs With Practical Strategies for Optimizing Asparaginase Therapy

Content Format:

Video

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

1.00
Amplifying the Academic/Community Connection to Equip HCPs With Practical Strategies for Optimizing Asparaginase Therapy

Content Format:

Slideset

Credit Type:

--

Credits:

--
Individualized Management of Acute Myeloid Leukemia: Guidance for the Community Multidisciplinary Team

Content Format:

Video

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
Individualized Management of Acute Myeloid Leukemia: Guidance for the Community Multidisciplinary Team

Content Format:

Slideset

Credit Type:

--

Credits:

--
Maintenance Strategies for AML Today: Experts Answer Frequently Asked Questions

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Critical Conversations in AML: Exploring Evidence-Based Maintenance Strategies

Content Format:

Video

Credit Type:

AMA

Credits:

1.00
Critical Conversations in AML: Exploring Evidence-Based Maintenance Strategies

Content Format:

Slideset

Credit Type:

--

Credits:

--
Key Studies in Leukemias: Independent Conference Coverage of ASH 2022

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.00